Immunology

On this edition of StudioTulsa, we meet immunologist Dr Eric Fajgenbaum, a researcher on the fairly rare disorder, Castleman's Disease. A survivor of this lymphatic condition himself, Fajgenbaum has devoted his work to discover how FDA-approved drugs can be repurposed to effectively fight Castleman's. 

On today's show, we listen back to a StudioTulsa on Health broadcast from October of last year. At that time, guest host John Henning Schumann spoke with Daniel M. Davis, a Professor of Immunology at the University of Manchester in the UK. The focal point of this discussion was the then-new book that Dr.

On this edition of StudioTulsa on Health, guest host John Henning Schumann conducts a fascinating interview with Daniel M. Davis, a Professor of Immunology at the University of Manchester in the UK, where he's also the Director of Research at the Manchester Collaborative Center for Inflammation Research. Dr.